Markets:

Overview

News

Currencies

International

Treasuries

Cencora, Inc. Common Stock (NY:COR)

282.63 +11.35 (+4.18%)

Streaming Delayed Price Updated: 12:37 PM EDT, Jun 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Top S&P500 movers in Monday's pre-market session ↗

May 12, 2025

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

Via Chartmill

Top S&P500 movers in Thursday's session ↗

May 08, 2025

Let's delve into the developments on the US markets one hour before the close of the markets on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Discover which S&P500 stocks are making waves on Thursday. ↗

May 08, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

Thursday's session: gap up and gap down stock in the S&P500 index ↗

May 08, 2025

Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Top S&P500 movers in Wednesday's session ↗

May 07, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings ↗

May 07, 2025

Cencora raised its 2025 earnings forecast after a strong Q2 driven by U.S. drug sales, though total revenue of $75.5 billion slightly missed expectations.

Via Benzinga

Cencora Reports Upbeat Q2 Earnings, Revises Fiscal Year 2025 Guidance: Retail’s Pleased ↗

May 07, 2025

The company raised its fiscal year 2025 adjusted EPS guidance to $15.70 to $15.95 compared to a previous range of $15.30 to $15.60.

Via Stocktwits

Cencora’s (NYSE:COR) Q1 Earnings Results: Revenue In Line With Expectations

May 07, 2025

Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 10.3% year on year to $75.45 billion. Its non-GAAP profit of $4.42 per share was 7.9% above...

Via StockStory

Topics Economy

Cencora Reports Fiscal 2025 Second Quarter Results

May 07, 2025

From Cencora

Via Business Wire

Cencora Earnings: What To Look For From COR

May 06, 2025

Healthcare distributor Cencora (NYSE:COR) will be reporting earnings tomorrow before the bell. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

Indications Suggest CENCORA INC (NYSE:COR) Could Be on the Verge of a Breakout. ↗

May 05, 2025

CENCORA INC (NYSE:COR) has a good technical rating of 10 out of 10 and could possibly break out.

Via Chartmill

Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years ↗

April 24, 2025

Via Benzinga

3 S&P 500 Stocks with Impressive Fundamentals

April 24, 2025

The biggest companies in the world call the S&P 500 (^GSPC) home, but only a handful are still growing rapidly. Some of these industry leaders are executing exceptionally well and rewarding...

Via StockStory

Topics Stocks

Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years ↗

April 17, 2025

Via Benzinga

Top S&P500 movers in Thursday's session ↗

April 10, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

These S&P500 stocks are moving in today's session ↗

April 09, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session.

Via Chartmill

Top 3 S&P 500 Winners in a Losing Market

April 09, 2025

Despite a broad market correction in 2025, three S&P 500 stocks have defied the downturn, delivering standout performance and showcasing strong fundamentals.

Via MarketBeat

Topics Earnings Stocks World Trade

These 5 S&P 500 Winners Held Strong In Q1 — Can The Rally Continue? ↗

April 07, 2025

A group of S&P 500 stocks have remained resilient as tariffs and earnings concerns cause the market to drop. Future gains may be limited.

Via Benzinga

Topics Stocks World Trade

Cencora: This ‘Recession-Proof’ Stock Just Set New Highs And Is Flashing ‘Buy’ Signals ↗

April 04, 2025

Valued at $54.20 billion, Cencora is a healthcare solutions provider formerly known as AmerisourceBergen, and is based in Conshohocken, Pennsylvania.

Via Talk Markets

Topics Stocks / Equities

3 Reasons COR Has Explosive Upside Potential

April 04, 2025

Since April 2020, the S&P 500 has delivered a total return of 101%. But one standout stock has more than doubled the market - over the past five years, Cencora has surged 231% to $285.36 per share. Its...

Via StockStory

Topics Stocks Supply Chain

Spotting Winners: Alignment Healthcare (NASDAQ:ALHC) And Health Insurance Providers Stocks In Q4

April 03, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Alignment Healthcare...

Via StockStory

Topics Artificial Intelligence Economy Fraud

Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

March 28, 2025

From Cencora

Via Business Wire

EXCLUSIVE: AdvisorShares Portfolio Manager Says Market 'Nervous' In 2025, Encourages Investors To Have 'Long-Term Focus' ↗

March 27, 2025

An ETF portfolio manager highlights how his fund is beating the broader market and what advice he has for investors in 2025 in an exclusive Benzinga interview.

Via Benzinga

Topics ETFs

Health Insurance Providers Stocks Q4 Highlights: CVS Health (NYSE:CVS)

March 27, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including CVS Health (NYSE:CVS) and its peers.

Via StockStory

Topics Artificial Intelligence Economy Fraud

Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years ↗

March 26, 2025

Via Benzinga

Q4 Earnings Highlights: Cencora (NYSE:COR) Vs The Rest Of The Health Insurance Providers Stocks

March 25, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Cencora (NYSE:COR) and its peers.

Via StockStory

Topics Artificial Intelligence Economy Fraud

3 Market-Beating Stocks to Target This Week

March 20, 2025

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends...

Via StockStory

What Analysts Are Saying About Cencora Stock ↗

March 14, 2025

Via Benzinga

Q4 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks

March 13, 2025

Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance providers earnings season.

Via StockStory

Topics Artificial Intelligence Economy Fraud

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.